Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older-Advisory Committee on Immunization Practices (ACIP), 2012 (Reprinted from MMWR, vol 61, pg 468-470, 2012)

被引:0
|
作者
不详
机构
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:968 / 970
页数:3
相关论文
共 25 条
  • [1] Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP), 2012
    Sawyer, Mark
    Liang, Jennifer L.
    Messonnier, Nancy
    Clark, Thomas A.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2013, 62 (07): : 131 - 135
  • [3] Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019
    Havers, Fiona P.
    Moro, Pedro L.
    Hunter, Paul
    Hariri, Susan
    Bernstein, Henry
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (03): : 77 - 83
  • [4] FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Reprinted from MMWR, vol 60, pg 1279-1280, 2011)
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (17): : 1856 - 1857
  • [5] FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Reprinted from MMWR, vol 58, pg 374-375, 2009)
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (08): : 841 - 841
  • [6] Adverse events after Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010
    Moro, Pedro L.
    Yue, Xin
    Lewis, Paige
    Haber, Penina
    Broder, Karen
    VACCINE, 2011, 29 (50) : 9404 - 9408
  • [7] Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018
    Haber, Penina
    Moro, Pedro L.
    Ng, Carmen
    Dores, Graca M.
    Perez-Vilar, Silvia
    Marquez, Paige L.
    Cano, Maria
    VACCINE, 2020, 38 (06) : 1476 - 1480
  • [8] Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedule for Adults Aged 19 Years and Older-United States, 2013 (Reprinted from MMWR, vol 62, pg 9, 2013)
    Bridges, C. B.
    Woods, L.
    Coyne-Beasley, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (05) : 1354 - 1363
  • [9] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (Reprinted from MMWR vol 40, pg 816, 2012)
    Bennett, Nancy M.
    Whitney, Cynthia G.
    Moore, Matt
    Pilishvili, Tamara
    Dooling, Kathleen L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (04): : 334 - 336
  • [10] Notes From the Field: Use of Tetanus, Diphtheria, and Pertussis Vaccine (Tdap) in an Emergency Department-Arizona, 2009-2010 (Reprinted from MMWR, vol 61, pg 55-56, 2012)
    Rhodes, Suzanne Michelle
    Hiller, Katherine
    Stolz, Uwe
    Hays, Dan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (16): : 1687 - 1688